These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, Fleming I. Circulation; 2004 Jan 20; 109(2):178-83. PubMed ID: 14662709 [Abstract] [Full Text] [Related]
4. The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment. Virdis A, Cetani F, Giannarelli C, Banti C, Ghiadoni L, Ambrogini E, Carrara D, Pinchera A, Taddei S, Bernini G, Marcocci C. J Clin Endocrinol Metab; 2010 Feb 20; 95(2):920-7. PubMed ID: 20022989 [Abstract] [Full Text] [Related]
14. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Circulation; 1999 Sep 28; 100(13):1400-5. PubMed ID: 10500040 [Abstract] [Full Text] [Related]
18. Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Schneider MP, Delles C, Schmidt BM, Oehmer S, Schwarz TK, Schmieder RE, John S. Am J Hypertens; 2005 Aug 28; 18(8):1111-7. PubMed ID: 16109326 [Abstract] [Full Text] [Related]
19. Age-related reduction of NO availability and oxidative stress in humans. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Hypertension; 2001 Aug 28; 38(2):274-9. PubMed ID: 11509489 [Abstract] [Full Text] [Related]